5 life lessons from Alan Thicke
The research and access to see and watch the process of photosynthesis is now on another level with X-ray.
An entrepreneur who made his fortune building a $14 billion tech company is setting up a life science venture capital fund. The Israel-focused fund will target maturing life science startups with a view to helping companies grow into the next Teva ($TEVA) rather than sell up or outlicense their programs.
Accel-KKR announced its investmen in Zinc Ahead.